Alerts
PDF
Other content recommended for you
- Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy
- CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS
- T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy
- Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
- Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study
- CIDP: mimics and chameleons
- Oligoclonal IgG bands in chronic inflammatory polyradiculoneuropathies
- Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy
- Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy
- Diagnosis and treatment in inflammatory neuropathies